Don't Ask Rambi Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Pastimes : Don't Ask Rambi

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Ilaine who wrote (25205)	5/20/1999 11:03:00 PM
From: Jacques Chitte	of 71178

Painkillers are a tough market segment. Efficacy is quite subjective. A pain med can be found to be well-tolerated, safe and clean. But if the efficacy results from clinical testing are ambivalent (smackadaisical - oops, leakage from another thread) then it could get killed by marketing. The drug has to work on a large percentage of testees. (there's a word I DON'T wanna mistype!) And it has to work better than the other leading brand. There are very effective pain meds available. The big frontier now is reducing side effects - notably "abuse potential". There are maybe a dozen biochemical beachheads being campaigned on the pain front. Most of those will be wiped out - maybe safety, maybe efficacy. It's a crapshoot.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next